首页 > 最新文献

Actas dermo-sifiliograficas最新文献

英文 中文
[[Translated article]]Trigeminal Trophic Syndrome: A Diagnosis to Be Kept in Mind. [三叉神经营养不良综合征:诊断需谨慎。
IF 3.8 Q1 DERMATOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.ad.2024.11.010
F G Moreno-Suárez, I L Labrot-Moreno Moleón, R Ruiz-Villaverde
{"title":"[[Translated article]]Trigeminal Trophic Syndrome: A Diagnosis to Be Kept in Mind.","authors":"F G Moreno-Suárez, I L Labrot-Moreno Moleón, R Ruiz-Villaverde","doi":"10.1016/j.ad.2024.11.010","DOIUrl":"https://doi.org/10.1016/j.ad.2024.11.010","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Documento de expertos de la AEDV sobre el manejo de infecciones venéreas ulcerativas. AEDV 关于溃疡性性病感染管理的专家文件。
IF 3.8 Q1 DERMATOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.ad.2024.11.012
C E Morales Munuera, F Montoya Conesa, N de Loredo, Elena Sendagorta

Currently, ulcerative sexually transmitted infections, including syphilis, herpes simplex virus (HSV), lymphogranuloma venereum (LGV), chancroid, donovanosis and, more recently, monkeypox (MPOX), represent a growing challenge for health care professionals. The incidence of syphilis and LGV has increased in recent years in Spain. Additionally, HSV, syphilis and chancroid can also increase the risk of HIV acquisition and transmission. The population groups most vulnerable to these infections are young people, men who have sex with men (MSM) and commercial sex workers.It is important to make a timely differential diagnosis since genital, anal, perianal, and oral ulcerative lesions may pose differential diagnosis with other infectious and non-infectious conditions such as candidiasis vulvovaginitis, traumatic lesions, carcinoma, aphthous ulcers, Behçet's disease, fixed drug eruption, or psoriasis. For this reason, the dermatologist plays a crucial role in the diagnosis and management of sexually transmitted infections.This chapter presents the main epidemiological, clinical and therapeutic features associated with these infections.

目前,溃疡性性传播感染,包括梅毒、单纯疱疹病毒(HSV)、淋巴肉芽肿(LGV)、软下疳、多诺万病以及最近出现的猴痘,对医护人员构成了越来越大的挑战。近年来,梅毒和 LGV 的发病率在西班牙有所上升。此外,人类乳头瘤病毒、梅毒和软下疳也会增加感染和传播艾滋病毒的风险。由于生殖器、肛门、肛周和口腔溃疡病变可能与其他感染性和非感染性疾病(如念珠菌性外阴阴道炎、外伤性病变、癌、阿弗他溃疡、白塞氏病、固定药物疹或银屑病)发生鉴别诊断,因此及时进行鉴别诊断非常重要。因此,皮肤科医生在性传播感染的诊断和治疗中起着至关重要的作用。本章将介绍与这些感染相关的主要流行病学、临床和治疗特点。
{"title":"Documento de expertos de la AEDV sobre el manejo de infecciones venéreas ulcerativas.","authors":"C E Morales Munuera, F Montoya Conesa, N de Loredo, Elena Sendagorta","doi":"10.1016/j.ad.2024.11.012","DOIUrl":"https://doi.org/10.1016/j.ad.2024.11.012","url":null,"abstract":"<p><p>Currently, ulcerative sexually transmitted infections, including syphilis, herpes simplex virus (HSV), lymphogranuloma venereum (LGV), chancroid, donovanosis and, more recently, monkeypox (MPOX), represent a growing challenge for health care professionals. The incidence of syphilis and LGV has increased in recent years in Spain. Additionally, HSV, syphilis and chancroid can also increase the risk of HIV acquisition and transmission. The population groups most vulnerable to these infections are young people, men who have sex with men (MSM) and commercial sex workers.It is important to make a timely differential diagnosis since genital, anal, perianal, and oral ulcerative lesions may pose differential diagnosis with other infectious and non-infectious conditions such as candidiasis vulvovaginitis, traumatic lesions, carcinoma, aphthous ulcers, Behçet's disease, fixed drug eruption, or psoriasis. For this reason, the dermatologist plays a crucial role in the diagnosis and management of sexually transmitted infections.This chapter presents the main epidemiological, clinical and therapeutic features associated with these infections.</p>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fusariosis angioinvasiva con expresión cutánea tras trasplante de progenitores hematopoyéticos. 造血干细胞移植后皮肤表现的血管侵袭性镰刀菌感染。
IF 3.8 Q1 DERMATOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.ad.2024.11.018
B Rodríguez Sánchez, F Arias Lotto, M M Santos Sebastián, M Campos Domínguez
{"title":"Fusariosis angioinvasiva con expresión cutánea tras trasplante de progenitores hematopoyéticos.","authors":"B Rodríguez Sánchez, F Arias Lotto, M M Santos Sebastián, M Campos Domínguez","doi":"10.1016/j.ad.2024.11.018","DOIUrl":"https://doi.org/10.1016/j.ad.2024.11.018","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Different Mutational Profiles of Subcutaneous Panniculitis-like T-cell Lymphoma and Lupus Panniculitis: An Additional Case Series. 皮下泛发性T细胞淋巴瘤和狼疮泛发性T细胞淋巴瘤的不同突变谱:新增病例系列。
IF 3.8 Q1 DERMATOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.ad.2024.11.006
S Machan, M Rodríguez, R Manso, J Borregón, C Chamizo, R Alonso-Alonso, J L Rodríguez-Peralto, M Á Torres Nieto, C Monteagudo, E García Toro, L Cerroni, C García, T Estrach, A García Herrera, B Ferrer, V García-Patos, N Segues, F J Díaz de la Pinta, J L Afonso-Martin, Y Peñate, M Á Limeres-Gonzalez, M Á González-Núñez, C González-Cruz, E García Fernández, L Cereceda, P Minguez, L de la Fuente, L Requena, S M Rodríguez-Pinilla

Background and objective: subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare cytotoxic T-cell lymphoma with indolent behavior, mostly present in women and associated with immunological diseases whose pathogenic background is still poorly understood. SPTCL is associated with lupus erythematosus panniculitis (LEP) and histologically misdiagnosed.

Objectives: the aim of our study was to identify mutations affecting the pathogenesis of both SPTCL and LEP.

Materials and methods: we studied a total of 10 SPTCL and 10 LEP patients using targeted Next Generation Sequencing and pyrosequencing. Differences in gene expression between molecular subgroups were investigated using NanoString technology. Clinical data were collected, and correlations sought with the molecular data obtained.

Results: the mutational profile of SPTCL and LEP is different. We identified fewer pathogenic mutations than previously reported in SPTCL, noting a single HAVCR2-mutated SPTCL case. Interestingly, 40% of our SPTCL cases showed the pathogenic TP53 (p.Pro72Arg) (P72R) variant. Although cases showing HAVCR2 mutations or the TP53 (P72R) variant had more severe symptomatic disease, none developed hemophagocytic syndrome (HPS). Furthermore, TP53 (P72R)-positive cases were characterized by a lower metabolic signaling pathway and higher levels of CD28 expression and Treg signaling genes. In addition, 30% of our cases featured the same mutation (T735C) of the epigenetic modificatory gene DNMT3A. None of the LEP cases showed mutations in any of the studied genes.

Conclusions: the mutational landscape of SPTCL is broader than previously anticipated. We describe, for the first time, the involvement of the TP53 (P72R) pathogenic variant in this subgroup of tumors, consider the possible role of different genetic backgrounds in the development of SPTCL, and conclude that LEP does not follow the same pathogenic pathway as SPTCL.

背景和目的:皮下泛发性类T细胞淋巴瘤(SPTCL)是一种罕见的细胞毒性T细胞淋巴瘤,表现为懒散性,多见于女性,与免疫学疾病相关,其致病背景仍不甚明了。SPTCL与红斑狼疮泛发性淋巴结炎(LEP)相关,在组织学上被误诊。目的:我们的研究旨在确定影响SPTCL和LEP发病机制的基因突变。材料与方法:我们使用靶向新一代测序技术和热释光测序技术共研究了10例SPTCL和10例LEP患者。使用 NanoString 技术研究了分子亚群之间基因表达的差异。结果:SPTCL 和 LEP 的基因突变情况不同。我们在SPTCL中发现的致病突变少于之前的报道,只发现一例HAVCR2突变的SPTCL病例。有趣的是,40%的SPTCL病例出现了致病性TP53(p.Pro72Arg)(P72R)变异。虽然出现HAVCR2突变或TP53(P72R)变异的病例症状更为严重,但没有一例出现嗜血细胞综合征(HPS)。此外,TP53(P72R)阳性病例的特点是代谢信号通路较低,CD28表达和Treg信号基因水平较高。此外,30%的病例具有相同的表观遗传修饰基因 DNMT3A 突变(T735C)。结论:SPTCL的基因突变情况比以前预期的要广泛。我们首次描述了 TP53(P72R)致病变异参与该亚组肿瘤的情况,考虑了不同遗传背景在 SPTCL 发病中可能扮演的角色,并得出结论认为 LEP 与 SPTCL 的发病途径不同。
{"title":"Different Mutational Profiles of Subcutaneous Panniculitis-like T-cell Lymphoma and Lupus Panniculitis: An Additional Case Series.","authors":"S Machan, M Rodríguez, R Manso, J Borregón, C Chamizo, R Alonso-Alonso, J L Rodríguez-Peralto, M Á Torres Nieto, C Monteagudo, E García Toro, L Cerroni, C García, T Estrach, A García Herrera, B Ferrer, V García-Patos, N Segues, F J Díaz de la Pinta, J L Afonso-Martin, Y Peñate, M Á Limeres-Gonzalez, M Á González-Núñez, C González-Cruz, E García Fernández, L Cereceda, P Minguez, L de la Fuente, L Requena, S M Rodríguez-Pinilla","doi":"10.1016/j.ad.2024.11.006","DOIUrl":"https://doi.org/10.1016/j.ad.2024.11.006","url":null,"abstract":"<p><strong>Background and objective: </strong>subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare cytotoxic T-cell lymphoma with indolent behavior, mostly present in women and associated with immunological diseases whose pathogenic background is still poorly understood. SPTCL is associated with lupus erythematosus panniculitis (LEP) and histologically misdiagnosed.</p><p><strong>Objectives: </strong>the aim of our study was to identify mutations affecting the pathogenesis of both SPTCL and LEP.</p><p><strong>Materials and methods: </strong>we studied a total of 10 SPTCL and 10 LEP patients using targeted Next Generation Sequencing and pyrosequencing. Differences in gene expression between molecular subgroups were investigated using NanoString technology. Clinical data were collected, and correlations sought with the molecular data obtained.</p><p><strong>Results: </strong>the mutational profile of SPTCL and LEP is different. We identified fewer pathogenic mutations than previously reported in SPTCL, noting a single HAVCR2-mutated SPTCL case. Interestingly, 40% of our SPTCL cases showed the pathogenic TP53 (p.Pro72Arg) (P72R) variant. Although cases showing HAVCR2 mutations or the TP53 (P72R) variant had more severe symptomatic disease, none developed hemophagocytic syndrome (HPS). Furthermore, TP53 (P72R)-positive cases were characterized by a lower metabolic signaling pathway and higher levels of CD28 expression and Treg signaling genes. In addition, 30% of our cases featured the same mutation (T735C) of the epigenetic modificatory gene DNMT3A. None of the LEP cases showed mutations in any of the studied genes.</p><p><strong>Conclusions: </strong>the mutational landscape of SPTCL is broader than previously anticipated. We describe, for the first time, the involvement of the TP53 (P72R) pathogenic variant in this subgroup of tumors, consider the possible role of different genetic backgrounds in the development of SPTCL, and conclude that LEP does not follow the same pathogenic pathway as SPTCL.</p>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[[Translated article]]RF - Safety and Efficacy of Isotretinoin for Moderate-to-Severe Seborrheic Dermatitis. [[翻译文章]]RF--异维A酸治疗中重度脂溢性皮炎的安全性和有效性。
IF 3.8 Q1 DERMATOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.ad.2024.11.016
Mar Luque-Luna, Javier Gil-Lianes, Ramon Pigem
{"title":"[[Translated article]]RF - Safety and Efficacy of Isotretinoin for Moderate-to-Severe Seborrheic Dermatitis.","authors":"Mar Luque-Luna, Javier Gil-Lianes, Ramon Pigem","doi":"10.1016/j.ad.2024.11.016","DOIUrl":"https://doi.org/10.1016/j.ad.2024.11.016","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resultados comunicados por el paciente, adherencia y satisfacción en pacientes con psoriasis. 银屑病患者的患者报告结果、依从性和满意度。
IF 3.8 Q1 DERMATOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.ad.2024.11.015
J Perales Pascual, H Navarro Aznárez, A López Pérez, T Gracia-Cazaña, Y Gilaberte Calzada, Mª R Abad Sazatornil

Background and objectives: Patient-reported outcomes (PROs) are outcomes evaluated by patients based on their perception of their disease and treatment. The objective of PROs is to determine antipsoriatic treatment-related adherence, quality of life (QoL) and satisfaction.

Materials and methods: We conducted an observational cross-sectional, prospective, and single-center study in which PROs surveys were conducted on adherence (Morisky-Green [MG] test), treatment satisfaction (Spanish Questionnaire of Treatment Satisfaction in Psoriasis [CESTEP]) and QoL (Skindex-29 and DLQI). Additional variables include: PASI, BSA.

Statistical analysis: Jamovi®2.3.26.

Results: A total of 100 surveys were conducted. Based on the MG questionnaire, we found that 75% (75/100) of patients were adherent vs 94% (94/100) from the dispensation records. Regarding CESTEP, a mean score of 7.4 ± 7.7 (close to maximum satisfaction 0) was obtained, while DLQI yielded a score of 2.6 ± 4.6 (indicating a small effect on QoL), and SKINDEX-29 a score of 14.6 ± 15.4 (68% indicating mild (< 5) or very mild (6-17) impact according to Nijsten et al.). Based on CESTEP a p.Rho Spearman value of 0.338 (p = 0.004) was obtained in relation to PASI when the study was conducted with a BSA of 0.255 (p = 0.050), DLQI results of 0.508 (p < 0.001) and Skindex-29 results of 0.397(p < 0.001). At the time of the study, the correlation matrix between DLQI result and PASI was 0.365 (p = 0.002) with a BSA of 0.347 (p = 0.007). Skindex-29 results with PASI were 0.380 (p = 0.001) and with BSA, 0.295 (p = 0.022).

Conclusions: Patients on therapy exhibit a good QoL, high adherence and satisfaction with their treatment. A significant correlation was seen among satisfaction, QoL, and PASI-BSA at the time of the study.

背景和目的:患者报告的结果(PROs)是患者根据自己对疾病和治疗的感知进行评估的结果。PROs的目的是确定与抗银屑病治疗相关的依从性、生活质量(QoL)和满意度:我们进行了一项观察性横断面、前瞻性和单中心研究,对患者的依从性(莫里斯基-格林[MG]测试)、治疗满意度(西班牙银屑病治疗满意度问卷[CESTEP])和生活质量(Skindex-29 和 DLQI)进行了 PROs 调查。其他变量包括统计分析:统计分析:Jamovi®2.3.26:共进行了 100 次调查。根据 MG 问卷,我们发现 75% (75/100)的患者坚持用药,而根据配药记录,坚持用药的患者比例为 94%(94/100)。关于 CESTEP,平均得分为 7.4 ± 7.7(接近最高满意度 0),而 DLQI 得分为 2.6 ± 4.6(表明对 QoL 的影响较小),SKINDEX-29 得分为 14.6 ± 15.4(根据 Nijsten 等人的研究,68% 表明影响轻微(< 5)或非常轻微(6-17))。根据 CESTEP,在进行 BSA 为 0.255(p = 0.050)、DLQI 为 0.508(p < 0.001)和 Skindex-29 为 0.397(p < 0.001)的研究时,PASI 的 p.Rho Spearman 值为 0.338(p = 0.004)。在研究期间,DLQI 结果与 PASI 之间的相关矩阵为 0.365(p = 0.002),BSA 为 0.347(p = 0.007)。Skindex-29结果与PASI的相关系数为0.380(p = 0.001),与BSA的相关系数为0.295(p = 0.022):结论:接受治疗的患者表现出良好的生活质量、较高的依从性和对治疗的满意度。结论:接受治疗的患者表现出良好的生活质量、较高的依从性和对治疗的满意度。在研究期间,满意度、生活质量和 PASI-BSA 之间存在明显的相关性。
{"title":"Resultados comunicados por el paciente, adherencia y satisfacción en pacientes con psoriasis.","authors":"J Perales Pascual, H Navarro Aznárez, A López Pérez, T Gracia-Cazaña, Y Gilaberte Calzada, Mª R Abad Sazatornil","doi":"10.1016/j.ad.2024.11.015","DOIUrl":"https://doi.org/10.1016/j.ad.2024.11.015","url":null,"abstract":"<p><strong>Background and objectives: </strong>Patient-reported outcomes (PROs) are outcomes evaluated by patients based on their perception of their disease and treatment. The objective of PROs is to determine antipsoriatic treatment-related adherence, quality of life (QoL) and satisfaction.</p><p><strong>Materials and methods: </strong>We conducted an observational cross-sectional, prospective, and single-center study in which PROs surveys were conducted on adherence (Morisky-Green [MG] test), treatment satisfaction (Spanish Questionnaire of Treatment Satisfaction in Psoriasis [CESTEP]) and QoL (Skindex-29 and DLQI). Additional variables include: PASI, BSA.</p><p><strong>Statistical analysis: </strong>Jamovi®2.3.26.</p><p><strong>Results: </strong>A total of 100 surveys were conducted. Based on the MG questionnaire, we found that 75% (75/100) of patients were adherent vs 94% (94/100) from the dispensation records. Regarding CESTEP, a mean score of 7.4 ± 7.7 (close to maximum satisfaction 0) was obtained, while DLQI yielded a score of 2.6 ± 4.6 (indicating a small effect on QoL), and SKINDEX-29 a score of 14.6 ± 15.4 (68% indicating mild (< 5) or very mild (6-17) impact according to Nijsten et al.). Based on CESTEP a p.Rho Spearman value of 0.338 (p = 0.004) was obtained in relation to PASI when the study was conducted with a BSA of 0.255 (p = 0.050), DLQI results of 0.508 (p < 0.001) and Skindex-29 results of 0.397(p < 0.001). At the time of the study, the correlation matrix between DLQI result and PASI was 0.365 (p = 0.002) with a BSA of 0.347 (p = 0.007). Skindex-29 results with PASI were 0.380 (p = 0.001) and with BSA, 0.295 (p = 0.022).</p><p><strong>Conclusions: </strong>Patients on therapy exhibit a good QoL, high adherence and satisfaction with their treatment. A significant correlation was seen among satisfaction, QoL, and PASI-BSA at the time of the study.</p>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
¿Hacemos un párpado nuevo?: reconstrucción de defecto total de párpado inferior tras escisión de léntigo maligno melanoma. 我们创造了一个新的眼睑:切除恶性黑色素瘤后重建全下眼睑缺损。
IF 3.8 Q1 DERMATOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.ad.2024.11.021
M E Iglesias Zamora, I Hiltun Cabredo, J Aróstegui Aguilar, S Oscoz Jaime
{"title":"¿Hacemos un párpado nuevo?: reconstrucción de defecto total de párpado inferior tras escisión de léntigo maligno melanoma.","authors":"M E Iglesias Zamora, I Hiltun Cabredo, J Aróstegui Aguilar, S Oscoz Jaime","doi":"10.1016/j.ad.2024.11.021","DOIUrl":"https://doi.org/10.1016/j.ad.2024.11.021","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refractory Lichen Sclerosus Treated With Fractional CO2 Laser-assisted Drug Delivery Photodynamic Therapy Using 5-Aminolevulinic Acid: A Case Series. 使用 5-Aminolevulinic Acid 的点阵 CO2 激光辅助给药光动力疗法治疗难治性硬皮病:病例系列。
IF 3.8 Q1 DERMATOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.ad.2024.11.009
L Mateu-Arrom, O Yélamos, C E Morales-Munera
{"title":"Refractory Lichen Sclerosus Treated With Fractional CO<sub>2</sub> Laser-assisted Drug Delivery Photodynamic Therapy Using 5-Aminolevulinic Acid: A Case Series.","authors":"L Mateu-Arrom, O Yélamos, C E Morales-Munera","doi":"10.1016/j.ad.2024.11.009","DOIUrl":"https://doi.org/10.1016/j.ad.2024.11.009","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[[Translated article]]Anonychia and Digital Deformity as a Presentation of Sarcoma with BCOR Genetic Alterations. [[译文]]无趾骨和数字畸形是BCOR基因改变肉瘤的一种表现。
IF 3.8 Q1 DERMATOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.ad.2024.11.019
F Moro-Bolado, L Martínez-Montalvo, O Al-Wattar-Ceballos, P Fernández-Pacheco
{"title":"[[Translated article]]Anonychia and Digital Deformity as a Presentation of Sarcoma with BCOR Genetic Alterations.","authors":"F Moro-Bolado, L Martínez-Montalvo, O Al-Wattar-Ceballos, P Fernández-Pacheco","doi":"10.1016/j.ad.2024.11.019","DOIUrl":"https://doi.org/10.1016/j.ad.2024.11.019","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "MPOX (Formerly Monkeypox): Review on the Most Relevant Clinical, Epidemiological, Diagnostic and Therapeutic Aspects for the Dermatologist". 评论 "MPOX(原猴痘):为皮肤科医生提供最相关的临床、流行病学、诊断和治疗方面的综述"。
IF 3.8 Q1 DERMATOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.ad.2024.11.007
Y Singh Pathania
{"title":"Comment on \"MPOX (Formerly Monkeypox): Review on the Most Relevant Clinical, Epidemiological, Diagnostic and Therapeutic Aspects for the Dermatologist\".","authors":"Y Singh Pathania","doi":"10.1016/j.ad.2024.11.007","DOIUrl":"https://doi.org/10.1016/j.ad.2024.11.007","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Actas dermo-sifiliograficas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1